April 7, 2021 -- Twist Bioscience has granted Stanford University access to its antibody discovery and optimization services and its "library of libraries" for biologics discovery.
Researchers from Stanford's Innovative Medicines Accelerator program will have access to the library, which consists of a range of preconstructed and validated synthetic antibody libraries and proprietary discovery and optimization capabilities of Twist Biopharma, a division of Twist Bioscience.
Twist and Stanford hope that the newly granted access to these resources will accelerate antibody discovery against a wide range of therapeutic targets.
Financial details of the deal were not disclosed.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
